Risk of developing life-threatening ventricular arrhythmia associated with terfenadine in comparison with over-the-counter antihistamines, ibuprofen and clemastine

This publication has 17 references indexed in Scilit:

• Terfenadine-Ketoconazole Interaction
  JAMA, 1993
• Effect of the Antiarrhythmic Agent Moricizine on Survival after Myocardial Infarction
  New England Journal of Medicine, 1992
• The cardiac arrhythmia suppression trial: Background, interim results and implications
  The American Journal of Cardiology, 1990
• Clinical and regulatory implications of the cardiac arrhythmia suppression trial
  The American Journal of Cardiology, 1990
• The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: A dangerous imbalance in the risk-benefit ratio
  American Heart Journal, 1989
• Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction
  New England Journal of Medicine, 1989
• Prevalence and characteristics of proarrhythmia from moricizine (Ethmozine®)
  The American Journal of Cardiology, 1989
• The long QT syndromes: A critical review, new clinical observations and a unifying hypothesis
  Progress in Cardiovascular Diseases, 1988
• The Importance of Adverse Reaction Reporting by Physicians
  Published by American Medical Association (AMA) ,1988
• Torsade de pointes due to quinidine: Observations in 31 patients
  American Heart Journal, 1984